FGF21 and obesity disorder: Treatment of HepG2 and primary mouse hepatocytes with curcumin (2 μM) for 6 h resulted in significantly reduced fibroblast growth factor 21 (Fgf21) resistance, a hepatokine that is paradoxically found to be elevated with obesity and diabetes, while having attenuated action [89].